about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
19.77
-0.33
(-1.64%)
74,644.7
XNAS Volume
XNAS 07 May, 2026 1:39 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..